Company Filing History:
Years Active: 2001
Title: The Innovative Contributions of Sharon Challberg
Introduction
Sharon Challberg is a notable inventor based in Boyds, MD (US). She has made significant contributions to the field of genetic testing through her innovative work. Her expertise and dedication have led to the development of a patented technology that addresses critical health issues.
Latest Patents
Challberg holds a patent for a "Non-radioactive hybridization assay and kit." This invention is designed for the detection of genetic defects, microbial infections, or viral infections, including human papillomavirus. The assay involves treating a test sample with a base and incubating it with nucleic acid probes that are specific for target nucleic acids. The hybrids formed are captured onto a solid phase coated with an anti-hybrid antibody, allowing for the elimination of unhybridized probes and the detection of the bound hybrids.
Career Highlights
Sharon Challberg has been associated with Digene Corporation, where she has contributed her expertise in developing innovative diagnostic solutions. Her work has been instrumental in advancing the field of molecular diagnostics, particularly in the detection of viral infections.
Collaborations
Challberg has collaborated with notable colleagues, including Chaka Impraim and Attila Lőrincz. These collaborations have further enhanced her research and development efforts in the field of genetic testing.
Conclusion
Sharon Challberg's contributions to the field of genetic diagnostics through her patented inventions highlight her role as an influential inventor. Her work continues to impact the healthcare industry positively, providing essential tools for the detection of various infections and genetic conditions.